117 related articles for article (PubMed ID: 20731537)
1. 800 mg Darunavir tablets prepared by hot melt extrusion.
Thommes M; Baert L; Rosier J
Pharm Dev Technol; 2011; 16(6):645-50. PubMed ID: 20731537
[TBL] [Abstract][Full Text] [Related]
2. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
3. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion.
Liu J; Zhang F; McGinity JW
Eur J Pharm Biopharm; 2001 Sep; 52(2):181-90. PubMed ID: 11522484
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
[TBL] [Abstract][Full Text] [Related]
5. Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.
Mohammed NN; Majumdar S; Singh A; Deng W; Murthy NS; Pinto E; Tewari D; Durig T; Repka MA
AAPS PharmSciTech; 2012 Dec; 13(4):1158-69. PubMed ID: 22961411
[TBL] [Abstract][Full Text] [Related]
6. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
7. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
[TBL] [Abstract][Full Text] [Related]
8. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
[TBL] [Abstract][Full Text] [Related]
9. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
[TBL] [Abstract][Full Text] [Related]
10. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
[TBL] [Abstract][Full Text] [Related]
11. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
12. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
Fukuda M; Miller DA; Peppas NA; McGinity JW
Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
[TBL] [Abstract][Full Text] [Related]
13. Drug dispersion degree and drug dissolution rate in Hybrane S1200-based instant-release matricial particles prepared by hot melt extrusion.
Ravina-Eirin E; Gomez-Amoza JL; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Jun; 41(6):1000-5. PubMed ID: 24874791
[TBL] [Abstract][Full Text] [Related]
14. Hot-melt extruded drug-loaded rods: evaluation of the mechanical properties for individual dosing via the Solid Dosage Pen.
Laukamp EJ; Thommes M; Breitkreutz J
Int J Pharm; 2014 Nov; 475(1-2):344-50. PubMed ID: 25195728
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the hyperbranched polymer Hybrane H1500 for production of matricial controlled-release particles by hot-melt extrusion.
Raviña-Eirín E; Sánchez-Rodríguez B; Gómez-Amoza JL; Martínez-Pacheco R
Int J Pharm; 2014 Jan; 461(1-2):469-77. PubMed ID: 24368108
[TBL] [Abstract][Full Text] [Related]
16. A preliminary assessment of the impact of hot-melt extrusion on the physico-mechanical properties of a tablet.
Boersen N; Lee TW; Shen XG; Hui HW
Drug Dev Ind Pharm; 2014 Oct; 40(10):1386-94. PubMed ID: 23957611
[TBL] [Abstract][Full Text] [Related]
17. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
18. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
[TBL] [Abstract][Full Text] [Related]
19. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
[TBL] [Abstract][Full Text] [Related]
20. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
Gonzalez YM; Ghaly ES
Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
